The lesser known effects of statins

British Medical Journal

Volumn 333, Issue 7576, 2006, Pages 980-981

  Thomsen, Reimar W ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BACTEREMIA; CLINICAL PRACTICE; COMMUNITY ACQUIRED PNEUMONIA; DRUG EFFECT; EDITORIAL; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; MORTALITY; PRIORITY JOURNAL; SEPSIS; SOCIOECONOMICS; BACTERIAL PNEUMONIA; COMMUNICABLE DISEASE; EQUIPMENT; HEALTH STATUS; NOTE;

COMMUNITY-ACQUIRED INFECTIONS; EFFECT MODIFIERS (EPIDEMIOLOGY); HEALTH STATUS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PNEUMONIA, BACTERIAL;

EID: 33750960521     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39024.513218.BE     Document Type: Editorial

References (13)

1. Heart Protection Study Collaborative Group. Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from randomised trial of 20 536 people. BMJ 2006 doi: 10.1136/bmj.38993.731725.BE.
2. Ehrenstein MR, Jury EC, Mauri C. Statins for atherosclerosis - as good as it gets? N Engl J Med 2005;352:73-5.
3. Rutishauser J. The role of statins in clinical medicine - LDL-cholesterol lowering and beyond. Swiss Med Wkly 2006;136:41-9.
4. Fedson DS. Pandemic influenza: a potential role for statins in treatment and prophylaxis. Clin Infect Dis 2006;43:199-205.
5. Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG. Statins: panacea for sepsis? Lancet Infect Dis 2006;6:242-8.
6. Majumdar SR, McAlister FA, Eurich DT, Padwal RS, Marrie TJ. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ 2006 doi: 10.1136/bmj.38992. 565972.7C.
7. Glynn RJ, Schneeweiss S, Wang PS, Levin R, Avorn J. Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin Epidemiol 2006;59:819-28.
8. Thomsen RW, Hundborg HH, Johnsen SP, Pedersen L, Sørensen HT, Schønheyder HC, et al. Statin use and mortality within 180 days after bacteremia: a population-based cohort study. Crit Care Med 2006;34:1080-6.
9. Kapoor AS, Kanji H, Buckingham J, Devereaux PJ, McAlister FA. How strong is the evidence for perioperative staun use? A systematic review of controlled studies. BMJ 2006 doi: 10.1136/bmj.39006.531146.BE.
10. Silva MA, Swanson AC, Gandhi PJ, Tataronis GR. Statin-related adverse events: a meta-analysis. Clin Ther 2006;28:26-35.
11. Merx MW, Weber C. Statins in the intensive care unit. Curr Opin Crit Care 2006;12:309-14.
12. Thomsen RW, Riis A, Nørgaard M, Jacobsen J, Christensen S, McDonald CJ, et al. Rising incidence and persistently high mortality of hospitalized pneumonia: a 10-year population-based study in Denmark. J Intern Med 2006;259:410-7.
13. Sørensen HT, Lash TL, Rothman KJ. Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies. Hepatology 2006;44:1075-82.